DOSSIER · 13F Holders · Q2 2026
TVTX 0.5 05/15/32
TRAVERE THERAPEUTICS INC
1 institutions still hold TRAVERE THERAPEUTICS INC as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 89422GAB3·1 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
1 institutions reported TVTX 0.5 05/15/32 in Q2 2026. Context Capital Management, LLC leads at 100.0% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.